NPPB and chronic kidney disease: Additionally, it resulted in further reductions in blood pressure and significantly improved cardiovascular biomarkers such as high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide (NT-proBNP), highlighting its potential to modulate both cardiac and renal risk profiles in patients with chronic kidney disease (CKD) and HF [3].